Â鶹ŮÓÅ

In 1988, I became one of the first U.S. physicians certified in the new specialty of geriatric medicine, which focuses on the health care of older adults. As an idealistic and optimistic 32-year-old geriatrician, I believed that this branch of medicine would undoubtedly emerge as a vibrant field of medicine, benefiting patients and society. I was also confident that when I reached older adulthood, the health care system would be ready to care for me. (Jerry H. Gurwitz, 7/24)

The expansion of Medicaid to the full extent permitted by the Affordable Care Act would provide health care coverage to a significant number of low-income individuals who are currently unable to afford private insurance or qualify for Medicaid, thus falling into the coverage gap. (Alex Gajewski, David Auerbach and Fabrizia Faustinella, 7/24)

Cutting-edge FDA-approved therapies made from human cells are now being used to treat cancer, diabetes, and other diseases. Currently, most approved cell-based therapies use an individual’s own cells, but the next generation of these therapies will be made from donor-derived blood and tissue. (Priya Baraniak, 7/24)

Healthcare is an ideal industry to examine the effects of consolidation because it is so crucial to the economy and every American's well-being. The industry represented 17.3% of U.S. gross domestic product in 2022. That’s $4.5 trillion, or more than $13,000 per person, according to federal data, epitomizing the central challenge of any industry: how to deliver the highest-quality service at the lowest cost. (James Calver, 7/23)